Literature DB >> 34087497

Amine-terminated dendritic polymers as promising nanoplatform for diagnostic and therapeutic agents' modification: A review.

Mahsa Delyanee1, Somaye Akbari2, Atefeh Solouk1.   

Abstract

It is often challenging to design diagnostic and therapeutic agents that fulfill all functional requirements. So, bulk and surface modifications as a common approach for biomedical applications have been suggested. There have been considerable research interests in using nanomaterials to the prementioned methods. Among all nanomaterials, dendritic materials with three-dimensional structures, host-guest properties, and nano-polymeric dimensions have received considerable attention. Amine-terminated dendritic structures including, polyamidoamine (PAMAM), polypropyleneimine (PPI), and polyethyleneimine (PEI), have been enormously utilized in bio-modification. This review briefly described the structure of these three common dendritic polymers and their use to modify diagnostic and therapeutic agents in six major applications, including drug delivery, gene delivery, biosensor, bioimaging, tissue engineering, and antimicrobial activity. The current review covers amine-terminated dendritic polymers toxicity challenging and improvement strategies as well.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Amine-terminated dendritic polymers (ATDPs); Biomedical applications; Diagnostic and therapeutic agents; Modification; Polyamidoamine (PAMAM); Polyethyleneimine (PEI); Polypropyleneimine (PPI)

Year:  2021        PMID: 34087497     DOI: 10.1016/j.ejmech.2021.113572

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

Review 1.  Targeted Drug Delivery for Chronic Lymphocytic Leukemia.

Authors:  Makhloufi Zoulikha; Wei He
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.200

2.  Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression.

Authors:  Feng Guo; Junfeng Ke; Zhengdong Fu; Wenzhao Han; Liping Wang
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.